Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epidermal Growth Factor Receptor, Excision-Repair Cross-Complementation Group 1 Protein, and Thymidylate Synthase Expression in Penile Cancer.

Clinical genitourinary cancer - 1 Oct 2016

Dorff Tanya B, Schuckman Anne K, Schwartz Rachel, Rashad Sadaf, Bulbul Ajaz, Cai Jie, Pinski Jacek, Ma Yanling, Danenberg Kathleen, Skinner Eila, Quinn David I

Abstract excerpt

OBJECTIVE: To describe the expression of tissue epidermal growth factor receptor (EGFR), excision-repair cross-complementation group 1 protein (ERCC1), and thymidylate synthase (TS) in patients with penile cancer and explore their association with stage and outcome. METHODS: A total of 52 patients with penile squamous cell cancer who were treated at the University of Southern California from 1995 to 2010 were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Squamous Cell
Share to Endonucleases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Staging

Share to Penile Neoplasms

Share to Proto-Oncogene Proteins p21(ras)

Share to Survival Analysis

Share to Thymidylate Synthase

Share to Up-Regulation

Source

Open in PubMed Open full text

Identifiers

PMID: 26935231
DOI: 10.1016/j.clgc.2016.01.013
PMCID: PMC7515776

Genes

EGFR
ERCC1
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epidermal Growth Factor Receptor, Excision-Repair Cross-Complementation Group 1 Protein, and Thymidylate Synthase Expression in Penile Cancer.PMID 26935231Read ↗

The molecular pathogenesis of penile carcinoma—current developments and understandingSemantic proximity Read ↗

Excision repair cross complementation group 1 immunohistochemical expression predicts objective response and cancer-specific survival in patients treated by Cisplatin-based induction chemotherapy for locally advanced head and neck squamous cell carcinoma.Semantic proximity Read ↗

Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinomaSemantic proximity Read ↗

EGFR mutational status in penile cancer.Semantic proximity Read ↗

Epidermal growth factor receptor (EGFR)-RAS signaling pathway in penile squamous cell carcinoma.Semantic proximity Read ↗

Alterations in epidermal growth factor receptors 1 and 2 in esophageal squamous cell carcinomas.Semantic proximity Read ↗

Thymidylate synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed/carboplatin.Semantic proximity Read ↗

ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma.Semantic proximity Read ↗

Comparing ERCC1 protein expression, mRNA levels, and genotype in squamous cell carcinomas of the head and neck treated with concurrent chemoradiation stratified by HPV status.Semantic proximity Read ↗

Association of Oncogenic Mutations in Patients With Advanced Cutaneous Squamous Cell Carcinomas Treated With Cetuximab.Semantic proximity Read ↗

Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck.Semantic proximity Read ↗

Case report of penile squamous cell carcinoma continuous treatment with BRCA2 mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.